Geode Capital Management
CHTP

Geode Capital Management’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Geode Capital Management’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-386,040
Closed -$2.13M – 3883
2014
Q1 		$2.13M Buy
386,040
+43,997
+13% +$221K ﹤0.01% 2296
2013
Q4 		$1.51M Buy
342,043
+39,540
+13% +$134K ﹤0.01% 2464
2013
Q3 		$911K Buy
302,503
+56,303
+23% +$162K ﹤0.01% 2649
2013
Q2 		$566K Buy
+246,200
New +$498K ﹤0.01% 2796

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Geode Capital Management's CHTP Position: Q2 2014 in Review

Geode Capital Management sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 386,040 shares — an estimated $2.13M sold.

Geode Capital Management first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $2.13M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Geode Capital Management reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Geode Capital Management sold 386,040 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $2.13M.
  • Geode Capital Management first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Geode Capital Management's CHELSEA THERAPEUTICS INT'L LTD position peaked at $2.13M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Geode Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.